Vanessa Gruben identifies a number of issues that must be addressed in developing an equitable and effective policy for safe fertility services in Ontario.
Alana Cattapan argues that newly announced funding for one cycle of IVF in Ontario is not the best way to reduce multiple birth rates or to increase access to assisted reproductive technologies. (This post first appeared in the Toronto Star).
Newly available documents show conflicts of interest for the FDA ethicist who investigated a fetal drug experiment. Alice Dreger and Ellen K. Feder explain.
Canadian health ethics researchers request action on problems at CIHR in letter to members of the Canadian Parliament and Senate.
Impact Ethics 